Astrazeneca Phar

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE203A01020
  • NSEID: ASTRAZEN
  • BSEID: 506820
INR
6,588.90
-120.3 (-1.79%)
BSENSE

Sep 24, 03:30 PM

BSE+NSE Vol: 5.22 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryAstrazeneca Phar VS Pharmaceuticals & Biotechnology
 
1D
-1.79%
-1.67%
1W
-1.28%
-0.99%
1M
-8.74%
-4.9%
YTD
-26.87%
-13.66%
1Y
-25.17%
-9.96%
3Y
43.62%
11.47%
5Y
113.65%
22.54%
10Y
589.18%
156.66%
  • Stock Absolute Returns
  • India SENSEXAbsolute Returns
stock-summaryPrice + Dividend
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0.54%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-22.17%
0.44%
-21.73%
6 Months
-20.52%
0.46%
-20.06%
1 Year
-25.17%
0.39%
-24.78%
2 Years
-16.6%
0.87%
-15.73%
3 Years
43.62%
1.95%
45.57%
4 Years
107.2%
3.57%
110.77%
5 Years
113.65%
3.80%
117.45%

Latest dividend: 35.83219514591726 per share ex-dividend date: Jul-31-2026

stock-summaryReturn Quartiles
What is a Quartile?

Quartile analysis gives a quick view of the performance of the stock with its peers and with the overall market. Companies are bucketed in 4 Quartiles as per their total returns generated; with each quartile consisting of 25% of the companies in the category.


Example: If there are 20 companies in an industry, the top 5 return giving companies would be bucketed in 1st quartile, next 5 companies in 2nd quartile and so on

Return Quartiles - by Closest Peers stock-summary
Inconsistent Performance

Astrazeneca Pharma India Ltd has not been a consistent performer in the YTD and longer periods

4
Quartile
quartile-4
QTD
-19.8%
4
Quartile
quartile-4
Mar-Jun
5.88%
3
Quartile
quartile-3
Dec-Mar
-13.88%
4
Quartile
quartile-4
YTD
-27.05%
1
Quartile
quartile-1
2025
23.26%
4
Quartile
quartile-4
2024
32.43%
Click on any of the quartiles for detailed breakdown
Return Quartiles - by Industry stock-summary
Inconsistent Performance

Astrazeneca Pharma India Ltd has not been a consistent performer in the YTD and longer periods

4
Quartile
quartile-4
QTD
-19.8%
4
Quartile
quartile-4
Mar-Jun
5.88%
2
Quartile
quartile-2
Dec-Mar
-13.88%
4
Quartile
quartile-4
YTD
-27.05%
1
Quartile
quartile-1
2025
23.26%
3
Quartile
quartile-3
2024
32.43%
Click on any of the quartiles for detailed breakdown
Return Quartiles - by Market Cap stock-summary
Inconsistent Performance

Astrazeneca Pharma India Ltd has not been a consistent performer in the YTD and longer periods

4
Quartile
quartile-4
QTD
-19.8%
4
Quartile
quartile-4
Mar-Jun
5.88%
2
Quartile
quartile-2
Dec-Mar
-13.88%
4
Quartile
quartile-4
YTD
-27.05%
1
Quartile
quartile-1
2025
23.26%
2
Quartile
quartile-2
2024
32.43%
Click on any of the quartiles for detailed breakdown
stock-summaryRisk Adjusted Returns v/s India SENSEX
stock-summaryReturns Beta
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
Footer loading